Call 1-877-744-5675

Please see SUTENT Medication Guide and full Prescribing Information, including BOXED WARNING regarding serious liver problems, or visit SUTENT.com.
Please see DAURISMO Medication Guide and full Prescribing Information, including BOXED WARNING regarding stillbirth or severe birth defects, or visit DAURISMO.com.
Please see BESPONSA full Prescribing Information, including BOXED WARNING regarding serious liver problems and increased risk of death after transplant, or visit BESPONSA.com.
Please see MYLOTARG full Prescribing Information, including BOXED WARNING regarding severe or fatal liver problems, or visit MYLOTARG.com.
Please see CAMPTOSAR full Prescribing Information, including BOXED WARNING for diarrhea and low blood cell counts.
Please see ELLENCE full Prescribing Information, including BOXED WARNING for effects on the heart, low blood cell counts, and risk of developing a certain type of blood cancer.
Please see IDAMYCIN full Prescribing Information, including BOXED WARNING for effects on the heart and low blood cell counts.
Please see RETACRIT Medication Guide and full Prescribing Information, including BOXED WARNING regarding increased risk of death, serious heart problems (including heart attack, heart failure, and stroke), blood clots (especially in the legs and lungs), and tumor growing faster, or visit RETACRIT.com.

 

BAVENCIO (avelumab) is jointly developed and commercialized by Merck KGaA, Darmstadt, Germany and Pfizer.

Please see full Prescribing Information for SUTENT, including BOXED WARNING for hepatotoxicity, or visit SUTENThcp.com.
Please see full Prescribing Information for DAURISMO, including BOXED WARNING for embryo-fetal toxicity, or visit DAURISMOhcp.com.
Please see full Prescribing Information for BESPONSA, including BOXED WARNING for hepatotoxicity, including VOD, and increased risk of post-HSCT non-relapse mortality; or visit BESPONSAhcp.com.
Please see full Prescribing Information for MYLOTARG, including BOXED WARNING for hepatotoxicity, or visit MYLOTARGhcp.com.
Please see full Prescribing Information for CAMPTOSAR, including BOXED WARNING for diarrhea and severe myelosuppression, or visit pfizerpro.com.
Please see full Prescribing Information for ELLENCE, including BOXED WARNING for myocardial toxicity, severe myelosuppression, secondary acute myelogenous leukemia (AML), dosing, and administration, or visit pfizerpro.com.
Please see full Prescribing Information for IDAMYCIN, including BOXED WARNING for myocardial toxicity, severe myelosuppression, dosing, and administration, or visit pfizerpro.com.
Please see full Prescribing Information for RETACRIT, including BOXED WARNING for increased risk of death, myocardial infarction, stroke, venous thromboembolism, thrombosis of vascular access, and tumor progression or recurrence, or visit RETACRIThcp.com.

 

BAVENCIO (avelumab) is jointly developed and commercialized by Merck KGaA, Darmstadt, Germany and Pfizer.

BACK TO TOP